PA
BIOA

Parallel Advisors’s BioAge Labs BIOA Stock Holding History

Parallel Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Hold
867
– – ﹤0.01% 2591
2026
Q1 		$15.2K Hold
867
– – ﹤0.01% 2588
2025
Q4 		$11.5K Buy
867
+567
+189% +$5.03K ﹤0.01% 2552
2025
Q3 		$1.76K Hold
300
– – ﹤0.01% 3085
2025
Q2 		$1.24K Sell
300
-431
-59% -$1.74K ﹤0.01% 3153
2025
Q1 		$2.75K Hold
731
– – ﹤0.01% 2879
2024
Q4 		$4.23K Hold
731
– – ﹤0.01% 2697
2024
Q3 		$15.2K Buy
+731
New +$14.6K ﹤0.01% 2223

Other funds holding BIOA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Parallel Advisors's BIOA Position: Q2 2026 in Review

Parallel Advisors held its BioAge Labs (BIOA) position steady in Q2 2026 at 867 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2591.

Parallel Advisors first reported a position in BIOA in Q3 2024 and has held it in 8 quarters since. 37 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Parallel Advisors held 867 shares of BioAge Labs worth $21.3K as of Q2 2026.
  • Parallel Advisors left its BioAge Labs share count unchanged in Q2 2026.
  • BioAge Labs made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2591 holding.
  • Parallel Advisors first reported a position in BioAge Labs in Q3 2024 and has held it in 8 quarters since.
  • 37 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.